Home ›
Organizations ›
COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS
COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS
DC · EIN 680299230
1
Executives Disclosed
$1.0M
Annual Revenue
$2.2M
Total Assets
COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS has 1 executive with disclosed compensation. The highest-paid executive, Michael Guastella (EXECUTIVE DIRECTOR), received peak total compensation of $260,040.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Michael Guastella | EXECUTIVE DIRECTOR | $260K | $260K | 2016–2024 | 3.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $202K | $202K | $202K |
| 2017 | 1 | $208K | $208K | $208K |
| 2018 | 1 | $214K | $214K | $214K |
| 2019 | 1 | $222K | $222K | $222K |
| 2020 | 1 | $228K | $228K | $228K |
| 2021 | 1 | $234K | $234K | $234K |
| 2022 | 1 | $240K | $240K | $240K |
| 2023 | 1 | $251K | $251K | $251K |
| 2024 | 1 | $260K | $260K | $260K |
Email Alerts
Get notified about COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.